4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000372
Director sold 8,000 shares at an average $509.98 ($4,079,823)
- Director acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STEER RANDOLPH C · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-07 | Exercise or conversion : show line 1 in the form | +4,000 | $87.39 | $349,560 | 9,112 | D |
| 2021-09-07 | Exercise or conversion : show line 2 in the form | +4,000 | $91.78 | $367,120 | 13,112 | D |
| 2021-09-07 | Sale : show line 3 in the form | −2,900 | $509.33 | $1,477,046 | 10,212 | D |
| 2021-09-07 | Sale : show line 4 in the form | −4,600 | $510.23 | $2,347,052 | 5,612 | D |
| 2021-09-07 | Sale : show line 5 in the form | −500 | $511.45 | $255,725 | 5,112 | D |
| Open-market sales · 8,000 sh · avg $509.98 · $4,079,823 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-07 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −4,000 | 0 | D |
| 2021-09-07 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −4,000 | 0 | D |
Loading xslF345X03/edgar.xml…